Cargando…

Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats

P-glycoprotein (P-gp) is known to transport a diverse array of xenobiotics, including therapeutic drugs. A member of the ATP-binding cassette (ABC) transporter family, P-gp is a protein encoded by the gene Mdr1 in humans and Abcb1 in rodents (represented by 2 isoforms Abcb1a and Abcb1b). Lining the...

Descripción completa

Detalles Bibliográficos
Autores principales: DeMars, Kelly M, Yang, Changjun, Hawkins, Kimberly E, McCrea, Austin O, Siwarski, David M, Candelario-Jalil, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398227/
https://www.ncbi.nlm.nih.gov/pubmed/28469478
http://dx.doi.org/10.1177/1179069517701741
_version_ 1783230420984266752
author DeMars, Kelly M
Yang, Changjun
Hawkins, Kimberly E
McCrea, Austin O
Siwarski, David M
Candelario-Jalil, Eduardo
author_facet DeMars, Kelly M
Yang, Changjun
Hawkins, Kimberly E
McCrea, Austin O
Siwarski, David M
Candelario-Jalil, Eduardo
author_sort DeMars, Kelly M
collection PubMed
description P-glycoprotein (P-gp) is known to transport a diverse array of xenobiotics, including therapeutic drugs. A member of the ATP-binding cassette (ABC) transporter family, P-gp is a protein encoded by the gene Mdr1 in humans and Abcb1 in rodents (represented by 2 isoforms Abcb1a and Abcb1b). Lining the luminal and abluminal membrane of brain capillary endothelial cells, P-gp is a promiscuous efflux pump extruding a variety of exogenous toxins and drugs. In this study, we measured dynamic changes in Abcb1a and Abcb1b transcripts and P-gp protein in the brain, liver, and kidney after experimental stroke. P-glycoprotein has been shown to increase in brain endothelial cells following hypoxia in vitro or after exposure to proinflammatory cytokines. Using a rat model of ischemic stroke, we hypothesized that P-gp expression will be increased in the brain, liver, and kidney in response to neuroinflammation following ischemic stroke. Adult Sprague Dawley rats underwent middle cerebral artery occlusion (MCAO) for 90 minutes and were killed at 4, 14, 24, and 48 hours postreperfusion onset to determine the time course of P-gp expression. To mimic ischemia occurring at the blood-brain barrier, rat brain endothelial (RBE4) cells were subjected to hypoxia and low glucose (HLG) for 16 hours. Immunoblotting analyses showed P-gp increases in brain and liver following 90-minute MCAO, as well as in cultured RBE4 cells after 16-hour HLG treatment, but fluctuated in the kidney depending on the time point. The relative roles of each isoform in the protein expression were analyzed with quantitative reverse transcriptase polymerase chain reaction. Ischemic stroke leads to significant increases in P-gp levels not only in the brain but also in the liver. The increase in P-gp could dramatically reduce the bioavailability and efficacy of neuroprotective drugs. Therefore, P-gp represents a big hurdle to drug delivery to the ischemic brain.
format Online
Article
Text
id pubmed-5398227
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-53982272017-05-03 Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats DeMars, Kelly M Yang, Changjun Hawkins, Kimberly E McCrea, Austin O Siwarski, David M Candelario-Jalil, Eduardo J Exp Neurosci Original Research P-glycoprotein (P-gp) is known to transport a diverse array of xenobiotics, including therapeutic drugs. A member of the ATP-binding cassette (ABC) transporter family, P-gp is a protein encoded by the gene Mdr1 in humans and Abcb1 in rodents (represented by 2 isoforms Abcb1a and Abcb1b). Lining the luminal and abluminal membrane of brain capillary endothelial cells, P-gp is a promiscuous efflux pump extruding a variety of exogenous toxins and drugs. In this study, we measured dynamic changes in Abcb1a and Abcb1b transcripts and P-gp protein in the brain, liver, and kidney after experimental stroke. P-glycoprotein has been shown to increase in brain endothelial cells following hypoxia in vitro or after exposure to proinflammatory cytokines. Using a rat model of ischemic stroke, we hypothesized that P-gp expression will be increased in the brain, liver, and kidney in response to neuroinflammation following ischemic stroke. Adult Sprague Dawley rats underwent middle cerebral artery occlusion (MCAO) for 90 minutes and were killed at 4, 14, 24, and 48 hours postreperfusion onset to determine the time course of P-gp expression. To mimic ischemia occurring at the blood-brain barrier, rat brain endothelial (RBE4) cells were subjected to hypoxia and low glucose (HLG) for 16 hours. Immunoblotting analyses showed P-gp increases in brain and liver following 90-minute MCAO, as well as in cultured RBE4 cells after 16-hour HLG treatment, but fluctuated in the kidney depending on the time point. The relative roles of each isoform in the protein expression were analyzed with quantitative reverse transcriptase polymerase chain reaction. Ischemic stroke leads to significant increases in P-gp levels not only in the brain but also in the liver. The increase in P-gp could dramatically reduce the bioavailability and efficacy of neuroprotective drugs. Therefore, P-gp represents a big hurdle to drug delivery to the ischemic brain. SAGE Publications 2017-04-07 /pmc/articles/PMC5398227/ /pubmed/28469478 http://dx.doi.org/10.1177/1179069517701741 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
DeMars, Kelly M
Yang, Changjun
Hawkins, Kimberly E
McCrea, Austin O
Siwarski, David M
Candelario-Jalil, Eduardo
Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
title Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
title_full Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
title_fullStr Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
title_full_unstemmed Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
title_short Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
title_sort spatiotemporal changes in p-glycoprotein levels in brain and peripheral tissues following ischemic stroke in rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398227/
https://www.ncbi.nlm.nih.gov/pubmed/28469478
http://dx.doi.org/10.1177/1179069517701741
work_keys_str_mv AT demarskellym spatiotemporalchangesinpglycoproteinlevelsinbrainandperipheraltissuesfollowingischemicstrokeinrats
AT yangchangjun spatiotemporalchangesinpglycoproteinlevelsinbrainandperipheraltissuesfollowingischemicstrokeinrats
AT hawkinskimberlye spatiotemporalchangesinpglycoproteinlevelsinbrainandperipheraltissuesfollowingischemicstrokeinrats
AT mccreaaustino spatiotemporalchangesinpglycoproteinlevelsinbrainandperipheraltissuesfollowingischemicstrokeinrats
AT siwarskidavidm spatiotemporalchangesinpglycoproteinlevelsinbrainandperipheraltissuesfollowingischemicstrokeinrats
AT candelariojalileduardo spatiotemporalchangesinpglycoproteinlevelsinbrainandperipheraltissuesfollowingischemicstrokeinrats